Expression and Prognostic Value of Mirna-29B in Peripheral Blood for Endometrial Cancer

References

• Parathyroid Cancer Treatment (PDQ(R)). Patient Version . PDQ Cancer Information Summaries. National Cancer Institute, Bethesda, USA (2002).
   Google Scholar
• Chovanec J , SelingerovaI, GreplovaKet al. Adjustment of serum HE4 to reduced glomerular filtration and its use in biomarker-based prediction of deep myometrial invasion in endometrial cancer. Oncotarget8(64), 108213–108222 (2017).
   PubMedGoogle Scholar
• Zhang H , WangX, ChenZ, WangW. microRNA-424 suppresses estradiol-induced cell proliferation via targeting GPER in endometrial cancer cells. Cell Mol. Biol. (Noisy-le-grand)61, 96–101 (2015).
   PubMed Web of Science ®Google Scholar
• Hampel H , FrankelW, PanescuJJet al. Screening for lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Cancer Res.66, 7810–7817 (2006).
   PubMed Web of Science ®Google Scholar
• Evans T , SanyO, PearmainPet al. Differential trends in the rising incidence of endometrial cancer by type: data from a UK population-based registry from 1994 to 2006. Br. J. Cancer104, 1505–1510 (2011).
   PubMed Web of Science ®Google Scholar
• Murali R , SoslowRA, WeigeltB. Classification of endometrial carcinoma: more than two types. Lancet Oncol.15(7), e268–e278 (2014).
   PubMed Web of Science ®Google Scholar
• Dong P , KaneuchiM, WatariHet al. microRNA-106b modulates epithelial–mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines. Mol. Carcinog.53, 349–359 (2014).
   PubMed Web of Science ®Google Scholar
• Sherman ME . Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod. Pathol.13, 295–308 (2000).
   PubMed Web of Science ®Google Scholar
• Hecht JL , MutterGL. Molecular and pathologic aspects of endometrial carcinogenesis. J. Clin. Oncol.24, 4783–4791 (2006).
   PubMed Web of Science ®Google Scholar
• Prat J , GallardoA, CuatrecasasMet al. Endometrial carcinoma: pathology and genetics. Pathology39, 72–87 (2007).
   PubMed Web of Science ®Google Scholar
• Saso S , ChatterjeeJ, GeorgiouEet al. Endometrial cancer. BMJ343, d3954 (2011).
   PubMedGoogle Scholar
• Galaal K , Al MoundhriM, BryantAet al. Adjuvant chemotherapy for advanced endometrial cancer. Cochrane Database Syst. Rev.5, CD010681 (2014).
   Google Scholar
• Ward KK , N ShahRN, SaenzCCet al. Cardiovascular disease is the leading cause of death among endometrial cancer patients. Gynecol. Oncol.126, 176–179 (2012).
   PubMed Web of Science ®Google Scholar
• McCullough ML , PatelAV, PatelRet al. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype. Cancer Epidemiol. Biomarkers Prev.17, 73–79 (2008).
   PubMed Web of Science ®Google Scholar
• Kim JW , KimSH, KimYTet al. Clinicopathologic and biological parameters predicting the prognosis in endometrial cancer. Yonsei Med. J.43, 769–778 (2002).
   PubMed Web of Science ®Google Scholar
• Vale CL , TierneyJ, BullSBet al. Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma. Cochrane Database Syst. Rev.8, CD003915 (2012).
   PubMedGoogle Scholar
• Favero G , PfifferT, RibeiroAet al. Laparoscopic sentinel lymph node detection after hysteroscopic injection of technetium-99 in patients with endometrial cancer. Int. J. Gynecol. Cancer25, 423–430 (2015).
   PubMed Web of Science ®Google Scholar
• Lawson EH , WrightVJ, FranconeTD. Robotic total abdominal hysterectomy with bilateral salpingo-oophorectomy and low anterior resection with transvaginal specimen extraction and intracorporeal colonic J-pouch construction: a multidisciplinary approach. Dis. Colon Rectum60, 353 (2017).
   PubMed Web of Science ®Google Scholar
• Gehrig PA , Bae-JumpVL. Promising novel therapies for the treatment of endometrial cancer. Gynecol. Oncol.116, 187–194 (2010).
   PubMed Web of Science ®Google Scholar
• Colombo N , PretiE, LandoniFet al. Endometrial cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol.24 (Suppl. 6), vi33–vi38 (2013).
   PubMed Web of Science ®Google Scholar
• Gao Y , LiuT, HuangY. microRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins. FEBS Lett.589, 207–214 (2015).
   PubMed Web of Science ®Google Scholar
• Ulfenborg B , JurcevicS, LindlofAet al. miREC: a database of miRNAs involved in the development of endometrial cancer. BMC Res. Notes8, 104 (2015).
   PubMedGoogle Scholar
• Ambros V . The functions of animal microRNAs. Nature431, 350–355 (2004).
   PubMed Web of Science ®Google Scholar
• Xu YY , TianJ, HaoQet al. microRNA-495 downregulates FOXC1 expression to suppress cell growth and migration in endometrial cancer. Tumour Biol.37, 239–251 (2016).
   PubMedGoogle Scholar
• Liu Y , TaylorNE, LuLet al. Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes. Hypertension55, 974–982 (2010).
   PubMed Web of Science ®Google Scholar
• Jamieson NB , MorranC, MortonJPet al. microRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinoma. Clin. Cancer Res.18, 534–545 (2012).
   PubMed Web of Science ®Google Scholar
• van Rooij E , SutherlandLB, ThatcherJEet al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl Acad. Sci. USA105, 13027–13032 (2008).
   PubMed Web of Science ®Google Scholar
• Rothschild SI , TschanMP, FederzoniEAet al. microRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma. Oncogene31, 4221–4232 (2012).
   PubMed Web of Science ®Google Scholar
• Qin W , ChungAC, HuangXRet al. TGF-beta/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J. Am. Soc. Nephrol.22, 1462–1474 (2011).
   PubMed Web of Science ®Google Scholar
• Wang B , LiW, LiuHet al. miR-29b suppresses tumor growth and metastasis in colorectal cancer via downregulating Tiam1 expression and inhibiting epithelial–mesenchymal transition. Cell Death Dis.5, e1335 (2014).
   PubMed Web of Science ®Google Scholar
• Verne J , FournierE, GervaisPet al. Direct stimulant effect of cyclic AMP and dibutryl cAMP on glycogenolysis by hepatocytes in histiotypic culture. Biomedicine19, 130–132 (1973).
   Google Scholar
• Habata S , IwasakiM, SugioAet al. BAG3 increases the invasiveness of uterine corpus carcinoma cells by suppressing miR-29b and enhancing MMP2 expression. Oncol. Rep.33, 2613–2621 (2015).
   PubMed Web of Science ®Google Scholar
• Pecorelli S . Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int. J. Gynaecol. Obstet.105, 103–104 (2009).
   PubMed Web of Science ®Google Scholar
• Selcuklu SD , DonoghueMT, SpillaneC. mir-21 as a key regulator of oncogenic processes. Biochem. Soc. Trans.37(Pt 4), 918–925 (2009).
   PubMedGoogle Scholar
• Liu H , WangB, LinJet al. microRNA-29b: an emerging player in human cancer. Asian Pac. J. Cancer Prev.15, 9059–9064 (2014).
   PubMedGoogle Scholar
• Nguyen T , KuoC, NichollMBet al. Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma. Epigenetics6, 388–394 (2011).
   PubMed Web of Science ®Google Scholar
• Han YC , ParkYC, BhagatGet al. microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid leukemia. J. Exp. Med.207, 475–489 (2010).
   PubMed Web of Science ®Google Scholar
• Jiang H , ZhangG, WuJHet al. Diverse roles of mir-29 in cancer (review). Oncol. Rep.31(4), 1509–1516 (2014).
   PubMed Web of Science ®Google Scholar
• Bartel DP . microRNAs: target recognition and regulatory functions. Cell136(2), 215–233 (2009).
   PubMed Web of Science ®Google Scholar
• Chen HX , XuXX, TanBZet al. microRNA-29b inhibits angiogenesis by targeting VEGFA through the MAPK/ERK and PI3K/Akt signaling pathways in endometrial carcinoma. Cell Physiol. Biochem.41, 933–946 (2017).
   PubMedGoogle Scholar
• Li Z , HassanMQ, JafferjiMet al. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J. Biol. Chem.284, 15676–15684 (2009).
   PubMed Web of Science ®Google Scholar
• Cortez MA , NicolosoMS, ShimizuMet al. mir-29b and mir-125a regulate podoplanin and suppress invasion in glioblastoma. Genes Chromosomes Cancer49(11), 981–990 (2010).
   PubMed Web of Science ®Google Scholar
• Xu H , CheungIY, GuoHFet al. microRNA mir-29 modulates expression of immunoinhibitory molecule b7-h3: potential implications for immune based therapy of human solid tumors. Cancer Res.69(15), 6275–6281 (2009).
   PubMed Web of Science ®Google Scholar
• Kleinsteuber K , HeeschK, SchattlingSet al. Decreased expression of miR-21, miR-26a, miR-29a, and miR-142–3p in CD4(+) T cells and peripheral blood from tuberculosis patients. PLoS ONE8, e61609 (2013).
   PubMed Web of Science ®Google Scholar
• Wang HY , TuYS, LongJet al. SRF-miR29b-MMP2 axis inhibits NSCLC invasion and metastasis. Int. J. Oncol.47, 641–649 (2015).
   PubMed Web of Science ®Google Scholar
• Fabbri M , GarzonR, CimminoAet al. microRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3a and 3b. Proc. Natl Acad. Sci. USA104(40), 15805–15810 (2007).
   PubMed Web of Science ®Google Scholar
• May K , BryantA, DickinsonHOet al. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst. Rev.9, CD007585 (2010).
   Google Scholar
• Dai F , ZhangY, ChenY. Involvement of miR-29b signaling in the sensitivity to chemotherapy in patients with ovarian carcinoma. Hum. Pathol.45, 1285–1293 (2014).
   PubMed Web of Science ®Google Scholar
• Bahador R , TaheriazamA, MirghasemiAet al. Tissue expression levels of miR-29b and miR-422a in children, adolescents, and young adults’ age groups and their association with prediction of poor prognosis in human osteosarcoma. Tumour Biol.37, 3091–3095 (2016).
   PubMedGoogle Scholar
• Dong CW , WangYX, DuFTet al. Low miR-29c expression is a prognostic marker in hepatocellular carcinoma. Genet. Mol. Res.15(3), doi:10.4238/gmr.15037316 (2016).
   Web of Science ®Google Scholar
• Vargas R , Rauh-HainJA, ClemmerJet al. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis. Gynecol. Oncol.133, 216–220 (2014).
   PubMed Web of Science ®Google Scholar
• Berretta R , PatrelliTS, MigliavaccaCet al. Assessment of tumor size as a useful marker for the surgical staging of endometrial cancer. Oncol. Rep.31, 2407–2412 (2014).
   PubMed Web of Science ®Google Scholar